Craft

HeartSciences

Stock Price

$3

2024-10-29

Market Capitalization

$2.7 M

2024-10-29

Revenue

$4.4 K

FY, 2025

HeartSciences Summary

Company Summary

Overview
HeartSciences (also known as Heart Test Laboratories) is a medical technology company focused on applying innovative AI-based technology to an ECG. It develops the MyoVista wavECG product candidate, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test.
Type
Public
Status
Active
Founded
2007
HQ
Southlake, TX, US | view all locations
Website
https://heartsciences.com/
Cybersecurity rating
Sectors

Key People

  • Andrew Simpson

    Andrew Simpson, Chairman and CEO, Board Member

  • Mark Hilz

    Mark Hilz, Chief Operating Officer, Board Member

  • Danielle Watson, Chief Financial Officer

  • Aaron Peterson

    Aaron Peterson, VP Research and Development

LocationsView all

1 location detected

  • Southlake, TX HQ

    United States

    550 Reserve Street, Suite 360

HeartSciences Financials

Summary Financials

Net income (Q3, 2026)
($2.0M)
Cash (Q3, 2026)
$3.4M
EBIT (Q3, 2026)
($1.9M)
Enterprise value
$3.4M

Footer menu